Pati Aji Achdiat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pati Aji Achdiat has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Retno Hesty Maharani
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran – Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia
17 shared publications - Hermin Aminah Usman
Department of Anatomical Pathology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, Indonesia
14 shared publications - Hendra Gunawan
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran – Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
11 shared publications - Retno Hesty Maharani
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia
11 shared publications - Eva Krishna Sutedja
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia
10 shared publications - Oki Suwarsa
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia
10 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
Buschke-Löwenstein Tumor Spectrum Giant Condyloma with Mixed High- and Low-Risk Human Papillomavirus (HPV) Coinfection in an Adolescent with Autoimmune Hemolytic Anemia (AIHA): A Case Report
Background: Buschke-Löwenstein tumor (BLT), or giant condyloma acuminatum (GCA) is a rare, locally aggressive HPV-associated anogenital lesion characterized by extensive verrucous proliferation and a recognized potential for malignant transformation. Although BLT is classically linked to low-risk HPV genotypes 6 and 11, coexisting high-risk oncogenic genotypes may increase oncogenic potential, particularly in immunocompromised individuals. Purpose: To report a rare case of BLT-spectrum giant condyloma in an adolescent girl with autoimmune hemolytic anemia (AIHA) and mixed HPV 11, 16, and 18 coinfection, and to discuss the associated diagnostic challenges and potential oncogenic risk from a low resource setting perspective. Case Report: A 16-year-old HIV-negative, unmarried adolescent presented with a progressively enlarging vulvar mass over 8 months, with marked growth over the preceding two months. Physical examination revealed a painful large verrucous condylomatous mass measuring 15 × 5 × 3 cm, covering the vaginal introitus. The lesion did not obstruct the urethral meatus. She also had severe AIHA requiring corticosteroid therapy and transfusion support. After multidisciplinary stabilization, excision and cauterization of vulvar, vaginal, and cervical lesions were performed, with the urethra protected intraoperatively using urinary catheter as a landmark. Histopathology showed papillomatous hyperplastic stratified squamous epithelium with marked acanthosis, hyperkeratosis, elongated rete ridges, and prominent koilocytotic changes, consistent with HPV-associated cytopathic effects, without stromal invasion or malignant transformation. Immunohistochemistry demonstrated increased Ki-67 proliferative activity, patchy (non-block) p16, and wild-type p53, consistent with a productive HPV-associated lesion without immunophenotypic evidence of transcriptionally active high-risk HPV or invasive carcinoma. HPV genotyping detected HPV 11, 16, and 18, whereas HPV 6 was negative. Conclusion: This case illustrates the diagnostic complexity of BLT-spectrum giant condyloma in adolescent with immune dysregulation. Despite benign histopathology, coexistence of high-risk HPV genotypes, rapid growth, and immunological impairment warrants cautious interpretation regarding potential premalignant risk and underscores the importance of adequate tissue sampling, long-term surveillance, and HPV prevention. These conclusions are based on a single case and should be interpreted accordingly.
- 1 November 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
Open AccessBuschke-Löwenstein Tumor Spectrum Giant Condyloma with Mixed High- and Low-Risk Human Papillomavirus (HPV) Coinfection in an Adolescent with Autoimmune Hemolytic Anemia (AIHA): A Case Report
Background: Buschke-Löwenstein tumor (BLT), or giant condyloma acuminatum (GCA) is a rare, locally aggressive HPV-associated anogenital lesion characterized by extensive verrucous proliferation and a recognized potential for malignant transformation. Although BLT is classically linked to low-risk HPV genotypes 6 and 11, coexisting high-risk oncogenic genotypes may increase oncogenic potential, particularly in immunocompromised individuals. Purpose: To report a rare case of BLT-spectrum giant condyloma in an adolescent girl with autoimmune hemolytic anemia (AIHA) and mixed HPV 11, 16, and 18 coinfection, and to discuss the associated diagnostic challenges and potential oncogenic risk from a low resource setting perspective. Case Report: A 16-year-old HIV-negative, unmarried adolescent presented with a progressively enlarging vulvar mass over 8 months, with marked growth over the preceding two months. Physical examination revealed a painful large verrucous condylomatous mass measuring 15 × 5 × 3 cm, covering the vaginal introitus. The lesion did not obstruct the urethral meatus. She also had severe AIHA requiring corticosteroid therapy and transfusion support. After multidisciplinary stabilization, excision and cauterization of vulvar, vaginal, and cervical lesions were performed, with the urethra protected intraoperatively using urinary catheter as a landmark. Histopathology showed papillomatous hyperplastic stratified squamous epithelium with marked acanthosis, hyperkeratosis, elongated rete ridges, and prominent koilocytotic changes, consistent with HPV-associated cytopathic effects, without stromal invasion or malignant transformation. Immunohistochemistry demonstrated increased Ki-67 proliferative activity, patchy (non-block) p16, and wild-type p53, consistent with a productive HPV-associated lesion without immunophenotypic evidence of transcriptionally active high-risk HPV or invasive carcinoma. HPV genotyping detected HPV 11, 16, and 18, whereas HPV 6 was negative. Conclusion: This case illustrates the diagnostic complexity of BLT-spectrum giant condyloma in adolescent with immune dysregulation. Despite benign histopathology, coexistence of high-risk HPV genotypes, rapid growth, and immunological impairment warrants cautious interpretation regarding potential premalignant risk and underscores the importance of adequate tissue sampling, long-term surveillance, and HPV prevention. These conclusions are based on a single case and should be interpreted accordingly.
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 19, 1-6
Anogenital Warts in an Elderly Male: Clinical and Public Health Perspectives
Anogenital warts (AGWS), caused by human papillomavirus (HPV), are among the most common sexually transmitted infections (STIs). Although AGWS is more commonly found in younger adults, cases in older individuals are increasingly being reported. A 76-year-old man presented with progressively enlarging brown papules in the genital area (penile base, scrotum, and left inguinal fold). Histopathological examination showed epidermal hyperplasia, papillomatosis, acanthosis, and koilocytosis. PCR examination confirmed low-risk HPV types 6 and 11. The patient reported a history of multiple sexual partners, did not use condoms during sexual intercourse, and had limited knowledge regarding STIs transmission based on a questionnaire. The patient was treated with cryotherapy and lesion excision. At the final observation, complete lesion resolution was achieved with no new lesions observed. In conclusion, this case highlights the importance of maintaining clinical awareness of AGWs in older adults. Thorough diagnostic evaluation, sexual health education, regular STIs screening, and counseling should be integrated into routine care for the elderly population.
- 1 November 2026
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 19, 1-6
Open AccessAnogenital Warts in an Elderly Male: Clinical and Public Health Perspectives
Anogenital warts (AGWS), caused by human papillomavirus (HPV), are among the most common sexually transmitted infections (STIs). Although AGWS is more commonly found in younger adults, cases in older individuals are increasingly being reported. A 76-year-old man presented with progressively enlarging brown papules in the genital area (penile base, scrotum, and left inguinal fold). Histopathological examination showed epidermal hyperplasia, papillomatosis, acanthosis, and koilocytosis. PCR examination confirmed low-risk HPV types 6 and 11. The patient reported a history of multiple sexual partners, did not use condoms during sexual intercourse, and had limited knowledge regarding STIs transmission based on a questionnaire. The patient was treated with cryotherapy and lesion excision. At the final observation, complete lesion resolution was achieved with no new lesions observed. In conclusion, this case highlights the importance of maintaining clinical awareness of AGWs in older adults. Thorough diagnostic evaluation, sexual health education, regular STIs screening, and counseling should be integrated into routine care for the elderly population.
- Open Access
- 24 October 2026
- Published by Wiley in Skin Research and Technology
- Vol. 32 (10)
Clinical and Diagnostic Insights into Penile Angiolymphoid Hyperplasia with Eosinophilia Based on a Case and Analysis of Previous Literature
Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare, benign vascular proliferation of unknown origin. It typically occurs in the head and neck region, but can occasionally manifest in unusual locations, such as the penis. Herein, we report a case of ALHE in a 46‐year‐old HIV‐infected male presenting with multiple pruritic whitish nodules on the penile shaft with a size ranging from 0.5 × 0.5 × 0.1 cm to 1.1 × 0.6 × 0.2 cm, initially suspected to be nodular condyloma lata. However, negative serological syphilis test results excluded this initial diagnosis. Histopathological findings were consistent with ALHE, revealing plump endothelial cells and inflammatory infiltrates consisting of lymphocytes and eosinophils. The lesions did not fully resolve with topical corticosteroid therapy, thus necessitating surgical excision. As with ALHE at other sites, recurrence is to be anticipated. Although the pathogenesis remains unclear, an association between ALHE and HIV has been reported. ALHE presents both diagnostic and therapeutic challenges, particularly when it occurs in sensitive areas, such as the penis. While the penis is an atypical site for ALHE, awareness of this disease is important for dermatologists, and it should be included in the differential diagnosis of a penile nodule.
- 24 October 2026
- Published by Wiley in Skin Research and Technology
- Vol. 32 (10)
Open AccessClinical and Diagnostic Insights into Penile Angiolymphoid Hyperplasia with Eosinophilia Based on a Case and Analysis of Previous Literature
Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare, benign vascular proliferation of unknown origin. It typically occurs in the head and neck region, but can occasionally manifest in unusual locations, such as the penis. Herein, we report a case of ALHE in a 46‐year‐old HIV‐infected male presenting with multiple pruritic whitish nodules on the penile shaft with a size ranging from 0.5 × 0.5 × 0.1 cm to 1.1 × 0.6 × 0.2 cm, initially suspected to be nodular condyloma lata. However, negative serological syphilis test results excluded this initial diagnosis. Histopathological findings were consistent with ALHE, revealing plump endothelial cells and inflammatory infiltrates consisting of lymphocytes and eosinophils. The lesions did not fully resolve with topical corticosteroid therapy, thus necessitating surgical excision. As with ALHE at other sites, recurrence is to be anticipated. Although the pathogenesis remains unclear, an association between ALHE and HIV has been reported. ALHE presents both diagnostic and therapeutic challenges, particularly when it occurs in sensitive areas, such as the penis. While the penis is an atypical site for ALHE, awareness of this disease is important for dermatologists, and it should be included in the differential diagnosis of a penile nodule.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 19, 1-10
Rapidly Progressive Perianal Giant Condyloma in an Immunocompetent Adolescent: An Unusual Abuse-Associated Case
Buschke–Löwenstein tumor (BLT) is a rare, locally aggressive variant of condyloma acuminata associated predominantly with HPV genotypes 6 and 11. It presents as a progressively enlarging, exophytic, verrucous mass in the anogenital region with infiltrative growth and potential for significant local destruction. Predisposing factors include diabetes mellitus, tobacco and alcohol use, pregnancy, chemotherapy, and immunosuppression; however, cases in immunocompetent individuals have been reported. A 15-year-old female presented with an 8.5 cm perianal verrucous mass. She had no comorbidities or conventional risk factors but reported sexual assault 1.5 years earlier. Histopathology confirmed giant condyloma acuminata, and PCR genotyping identified HPV type 11. Laboratory findings, including HIV serology, were unremarkable. Complete surgical excision was performed without complications. At the one-month follow-up after the excision procedure, all lesions had disappeared, and no new lesions had appeared. This case highlights the unusual occurrence of BLT in an immunocompetent adolescent after sexual assault and emphasizes the importance of early recognition, consideration of underlying abuse, and timely management to prevent disease progression.
- 1 May 2026
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 19, 1-10
Open AccessRapidly Progressive Perianal Giant Condyloma in an Immunocompetent Adolescent: An Unusual Abuse-Associated Case
Buschke–Löwenstein tumor (BLT) is a rare, locally aggressive variant of condyloma acuminata associated predominantly with HPV genotypes 6 and 11. It presents as a progressively enlarging, exophytic, verrucous mass in the anogenital region with infiltrative growth and potential for significant local destruction. Predisposing factors include diabetes mellitus, tobacco and alcohol use, pregnancy, chemotherapy, and immunosuppression; however, cases in immunocompetent individuals have been reported. A 15-year-old female presented with an 8.5 cm perianal verrucous mass. She had no comorbidities or conventional risk factors but reported sexual assault 1.5 years earlier. Histopathology confirmed giant condyloma acuminata, and PCR genotyping identified HPV type 11. Laboratory findings, including HIV serology, were unremarkable. Complete surgical excision was performed without complications. At the one-month follow-up after the excision procedure, all lesions had disappeared, and no new lesions had appeared. This case highlights the unusual occurrence of BLT in an immunocompetent adolescent after sexual assault and emphasizes the importance of early recognition, consideration of underlying abuse, and timely management to prevent disease progression.
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 19, 1-15
Histopathological Features and p16/p62 Expression as Indicators of High-Risk HPV Co-Infection in Anogenital Condyloma Acuminata
Background: Condyloma acuminata (CA) is primarily caused by low-risk human papillomavirus (LR-HPV); however, high-risk HPV (HR-HPV) co-infection is increasingly reported and cannot be reliably distinguished based on clinical appearance alone. Histopathological assessment and selected immunohistochemical markers may help identify lesions with greater biological risk. Objective: To evaluate the association between histopathological features, p16 and p62 expression, and HR-HPV co-infection in anogenital CA. Methods: This cross-sectional study included 81 histopathologically confirmed CA cases. Semi-quantitative scoring was applied to lesion morphology, keratinization patterns, koilocytosis, atypical mitoses, and lymphocytic infiltration. p16 and p62 expression were assessed immunohistochemically. HPV genotyping was performed using real-time PCR. Variables significant in bivariate analysis were entered into multivariate logistic regression. Results: HR-HPV co-infection was detected in 59.3% of cases, with HPV-16 as the most frequent genotype. Hyperkeratosis (aOR = 4.29; p = 0.039) and atypical mitotic activity (aOR = 14.29; p < 0.001) were independently associated with HR-HPV co-infection. Parakeratosis and koilocytosis showed inverse associations. p16 and p62 were not independent predictors, although p16 block positivity correlated with high p62 expression (p < 0.001). Conclusion: Certain histopathological features, particularly atypical mitoses and hyperkeratosis, are associated with HR-HPV co-infection in anogenital CA. Routine histopathological evaluation may therefore provide practical clues to identify lesions that warrant closer clinical attention, while p16 and p62 offer complementary biological information. Plain Language Summary: Condyloma acuminata, also known as genital warts, is usually caused by low-risk types of human papillomavirus (HPV). However, some genital warts also contain high-risk HPV types that are associated with a greater chance of developing serious disease. These high-risk infections cannot always be recognized by visual examination alone, especially in healthcare settings without access to specialized HPV tests. In this study, we examined genital wart tissue under a microscope for features that might indicate a high-risk HPV infection. We focused on visible changes in the skin cells, such as abnormal cell division and thickening of the outer skin layer. We also studied two laboratory markers, p16 and p62, which reflect how cells respond to HPV infection. We found that abnormal cell division and certain keratinization changes were more common in warts with high-risk HPV. In contrast, p16 and p62 alone could not reliably identify high-risk HPV. These results show that routine microscopic examination can still provide useful clues about which genital warts may require closer medical attention. This is particularly valuable in settings where advanced HPV testing is unavailable, helping doctors and pathologists determine which patients may benefit from closer monitoring.
- 1 April 2026
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 19, 1-15
Open AccessHistopathological Features and p16/p62 Expression as Indicators of High-Risk HPV Co-Infection in Anogenital Condyloma Acuminata
Background: Condyloma acuminata (CA) is primarily caused by low-risk human papillomavirus (LR-HPV); however, high-risk HPV (HR-HPV) co-infection is increasingly reported and cannot be reliably distinguished based on clinical appearance alone. Histopathological assessment and selected immunohistochemical markers may help identify lesions with greater biological risk. Objective: To evaluate the association between histopathological features, p16 and p62 expression, and HR-HPV co-infection in anogenital CA. Methods: This cross-sectional study included 81 histopathologically confirmed CA cases. Semi-quantitative scoring was applied to lesion morphology, keratinization patterns, koilocytosis, atypical mitoses, and lymphocytic infiltration. p16 and p62 expression were assessed immunohistochemically. HPV genotyping was performed using real-time PCR. Variables significant in bivariate analysis were entered into multivariate logistic regression. Results: HR-HPV co-infection was detected in 59.3% of cases, with HPV-16 as the most frequent genotype. Hyperkeratosis (aOR = 4.29; p = 0.039) and atypical mitotic activity (aOR = 14.29; p < 0.001) were independently associated with HR-HPV co-infection. Parakeratosis and koilocytosis showed inverse associations. p16 and p62 were not independent predictors, although p16 block positivity correlated with high p62 expression (p < 0.001). Conclusion: Certain histopathological features, particularly atypical mitoses and hyperkeratosis, are associated with HR-HPV co-infection in anogenital CA. Routine histopathological evaluation may therefore provide practical clues to identify lesions that warrant closer clinical attention, while p16 and p62 offer complementary biological information. Plain Language Summary: Condyloma acuminata, also known as genital warts, is usually caused by low-risk types of human papillomavirus (HPV). However, some genital warts also contain high-risk HPV types that are associated with a greater chance of developing serious disease. These high-risk infections cannot always be recognized by visual examination alone, especially in healthcare settings without access to specialized HPV tests. In this study, we examined genital wart tissue under a microscope for features that might indicate a high-risk HPV infection. We focused on visible changes in the skin cells, such as abnormal cell division and thickening of the outer skin layer. We also studied two laboratory markers, p16 and p62, which reflect how cells respond to HPV infection. We found that abnormal cell division and certain keratinization changes were more common in warts with high-risk HPV. In contrast, p16 and p62 alone could not reliably identify high-risk HPV. These results show that routine microscopic examination can still provide useful clues about which genital warts may require closer medical attention. This is particularly valuable in settings where advanced HPV testing is unavailable, helping doctors and pathologists determine which patients may benefit from closer monitoring.
- Open Access
- 1 March 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-8
Unusual Presentation of Syphilis a Case Report: Areolar Condyloma Lata in a Patient with Human Immunodeficiency Virus Infection
Syphilis is a sexually transmitted infection caused by Treponema pallidum, primarily transmitted by sexual intercourse. Secondary syphilis is characterized by lesions on the skin and mucosal membranes, including condyloma lata (CL), occurring in 17% of secondary syphilis cases. Papules or flat-colored skin plaques are characteristic of CL. They are typically found in humid regions, such as skin folds, including the labia majora, perianal area, axilla, interdigital spaces, and inframammary folds. Presentation in an open region of the body, such as the nipple and the surrounding area of the breast, is rare. Herein we report a case of a 30-year-old female presenting with papules on both breasts and roseola syphilitica with Biett’s collarette on both palms and soles that had not been pruritic nor painful for three weeks. The patient has been treated for human immunodeficiency virus (HIV) for the past year. The patient was involved in prostitution for three years, with a total of 6 sexual partners. T. pallidum Hemagglutination Assay (TPHA) and the Venereal Disease Research Laboratory (VDRL) were reactive, with a VDRL titer of 1:8. The patient received a single dose of benzathine penicillin 2.4 million IU injected intramuscularly. The histopathology examination from papules on the breast confirmed the diagnosis of CL, which revealed lymphoplasmacytic infiltrates around the blood vessels and plump endothelial cells. The skin-colored papules on both areolas and the rash associated with secondary syphilis on both palms and soles began to fade two weeks after the intramuscular injection of single dose benzathine penicillin 2.4 million IU. Unusual presentation of secondary syphilis outside predilection sites is possible. A high degree of suspicion is warranted when unusual papules are present, especially with a background of multiple sexually transmitted diseases and immunocompromised condition.
- 1 March 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-8
Open AccessUnusual Presentation of Syphilis a Case Report: Areolar Condyloma Lata in a Patient with Human Immunodeficiency Virus Infection
Syphilis is a sexually transmitted infection caused by Treponema pallidum, primarily transmitted by sexual intercourse. Secondary syphilis is characterized by lesions on the skin and mucosal membranes, including condyloma lata (CL), occurring in 17% of secondary syphilis cases. Papules or flat-colored skin plaques are characteristic of CL. They are typically found in humid regions, such as skin folds, including the labia majora, perianal area, axilla, interdigital spaces, and inframammary folds. Presentation in an open region of the body, such as the nipple and the surrounding area of the breast, is rare. Herein we report a case of a 30-year-old female presenting with papules on both breasts and roseola syphilitica with Biett’s collarette on both palms and soles that had not been pruritic nor painful for three weeks. The patient has been treated for human immunodeficiency virus (HIV) for the past year. The patient was involved in prostitution for three years, with a total of 6 sexual partners. T. pallidum Hemagglutination Assay (TPHA) and the Venereal Disease Research Laboratory (VDRL) were reactive, with a VDRL titer of 1:8. The patient received a single dose of benzathine penicillin 2.4 million IU injected intramuscularly. The histopathology examination from papules on the breast confirmed the diagnosis of CL, which revealed lymphoplasmacytic infiltrates around the blood vessels and plump endothelial cells. The skin-colored papules on both areolas and the rash associated with secondary syphilis on both palms and soles began to fade two weeks after the intramuscular injection of single dose benzathine penicillin 2.4 million IU. Unusual presentation of secondary syphilis outside predilection sites is possible. A high degree of suspicion is warranted when unusual papules are present, especially with a background of multiple sexually transmitted diseases and immunocompromised condition.
- Open Access
- 4 February 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2612814
Impact of intralesional tuberculin PPD injection on anogenital warts: Interferon-α, interleukin-2, and treatment outcomes
The clinical manifestation of anogenital warts (AGW) resulting from Human Papillomavirus (HPV) infection is influenced by host immune responses. Interferon (IFN)-α contributes to antiviral activity, while Interleukin (IL)-2 plays an important role in cellular immunity. Tuberculin purified protein derivative (TPPD) has been investigated as an immunotherapeutic agent. This exploratory quasi-experimental study analyzed 12 AGW patients treated with intralesional TPPD (5 tuberculin units weekly for six injections). Tissue samples were collected at baseline and week 2, and serum samples at baseline and week 6. IFN-α and IL-2 expression in tissue was assessed using immunohistochemistry (IHC), and serum levels were measured using ELISA. TPPD therapy was associated with increased IFN-α and IL-2 expression in tissue (p = .047 and p = .019) and higher serum IL-2 levels (p = .030), while serum IFN-α did not change significantly. Clinically, 4 of 12 patients achieved complete response, whereas others showed partial, minimal, or no improvement, and 6 patients required subsequent destructive treatment. Local and systemic cytokine changes did not correlate with lesion regression. These findings suggest that cytokine upregulation reflects immune activation rather than determining lesion clearance, and between-group comparisons should be interpreted cautiously due to baseline.
- 4 February 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2612814
Open AccessImpact of intralesional tuberculin PPD injection on anogenital warts: Interferon-α, interleukin-2, and treatment outcomes
The clinical manifestation of anogenital warts (AGW) resulting from Human Papillomavirus (HPV) infection is influenced by host immune responses. Interferon (IFN)-α contributes to antiviral activity, while Interleukin (IL)-2 plays an important role in cellular immunity. Tuberculin purified protein derivative (TPPD) has been investigated as an immunotherapeutic agent. This exploratory quasi-experimental study analyzed 12 AGW patients treated with intralesional TPPD (5 tuberculin units weekly for six injections). Tissue samples were collected at baseline and week 2, and serum samples at baseline and week 6. IFN-α and IL-2 expression in tissue was assessed using immunohistochemistry (IHC), and serum levels were measured using ELISA. TPPD therapy was associated with increased IFN-α and IL-2 expression in tissue (p = .047 and p = .019) and higher serum IL-2 levels (p = .030), while serum IFN-α did not change significantly. Clinically, 4 of 12 patients achieved complete response, whereas others showed partial, minimal, or no improvement, and 6 patients required subsequent destructive treatment. Local and systemic cytokine changes did not correlate with lesion regression. These findings suggest that cytokine upregulation reflects immune activation rather than determining lesion clearance, and between-group comparisons should be interpreted cautiously due to baseline.
- Open Access
- 1 January 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-14
Leprosy in Pregnancy: A Systematic Review of Maternal Characteristics, Complications, and Neonatal Outcomes
Background: Nearly 40% of leprosy cases occur in females. Although relatively uncommon in pregnancy, immunological changes during gestation and the puerperium may exacerbate leprosy and influence maternal and neonatal outcomes. To date, no systematic review has synthesized the evidence on leprosy in pregnancy. Purpose: To describe maternal clinical and obstetric characteristics, pregnancy complications, neonatal outcomes, and laboratory findings in pregnant women with leprosy. Methods: We systematically searched electronic databases from inception to August 2025 for studies reporting leprosy in pregnancy or puerperium using specific terms and inclusion/exclusion criteria. Data were extracted and presented descriptively. Results: Eighteen case reports and case series described a total of 21 individual patients, while an additional eight original articles were included. Most patients were aged 20– 39 years (85.7%), with multibacillary leprosy predominating (80.9%) of cases. Erythema nodosum leprosum was more frequent during pregnancy (14.3%), while reversal reactions predominated in the puerperium (9.5%). Leprosy in pregnancy was most frequently reported in the third trimester (52.4%). Cesarean section was slightly more frequent than vaginal delivery (33.3% vs 23.8%). Overall, maternal and neonatal outcomes were generally favorable, although complications included intrauterine growth restriction, hematologic abnormalities, preterm delivery, neonatal skin discoloration, and hyperbilirubinemia. One infant was diagnosed with leprosy at six months. Slit-skin smears were occasionally positive with a high bacteriological index, and acid-fast bacilli were detected in the placentas of mothers with leprosy. Conclusion: Leprosy in pregnancy most often affects women of reproductive age with the multibacillary type, typically presenting in the third trimester. While maternal and neonatal outcomes are generally favorable, complications may occur, underscoring the importance of continuing multidrug therapy with close monitoring. Further multicenter studies are required to better define transmission risks and optimize management strategies.
- 1 January 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-14
Open AccessLeprosy in Pregnancy: A Systematic Review of Maternal Characteristics, Complications, and Neonatal Outcomes
Background: Nearly 40% of leprosy cases occur in females. Although relatively uncommon in pregnancy, immunological changes during gestation and the puerperium may exacerbate leprosy and influence maternal and neonatal outcomes. To date, no systematic review has synthesized the evidence on leprosy in pregnancy. Purpose: To describe maternal clinical and obstetric characteristics, pregnancy complications, neonatal outcomes, and laboratory findings in pregnant women with leprosy. Methods: We systematically searched electronic databases from inception to August 2025 for studies reporting leprosy in pregnancy or puerperium using specific terms and inclusion/exclusion criteria. Data were extracted and presented descriptively. Results: Eighteen case reports and case series described a total of 21 individual patients, while an additional eight original articles were included. Most patients were aged 20– 39 years (85.7%), with multibacillary leprosy predominating (80.9%) of cases. Erythema nodosum leprosum was more frequent during pregnancy (14.3%), while reversal reactions predominated in the puerperium (9.5%). Leprosy in pregnancy was most frequently reported in the third trimester (52.4%). Cesarean section was slightly more frequent than vaginal delivery (33.3% vs 23.8%). Overall, maternal and neonatal outcomes were generally favorable, although complications included intrauterine growth restriction, hematologic abnormalities, preterm delivery, neonatal skin discoloration, and hyperbilirubinemia. One infant was diagnosed with leprosy at six months. Slit-skin smears were occasionally positive with a high bacteriological index, and acid-fast bacilli were detected in the placentas of mothers with leprosy. Conclusion: Leprosy in pregnancy most often affects women of reproductive age with the multibacillary type, typically presenting in the third trimester. While maternal and neonatal outcomes are generally favorable, complications may occur, underscoring the importance of continuing multidrug therapy with close monitoring. Further multicenter studies are required to better define transmission risks and optimize management strategies.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 5787-5795
Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome
Background: Linear morphea (LM) is a chronic autoimmune disease characterized by linear or band-like localized sclerosis that may involve the dermis, subcutaneous tissue, muscle, and underlying bone. While LM typically presents in childhood, adult-onset disease is considerably less common, and LM presenting during breastfeeding has not, to our knowledge, been previously documented. As a result, therapeutic guidance for managing LM in breastfeeding women remains extremely limited, highlighting the need for additional clinical evidence in this population. Case Presentation: A 44-year-old breastfeeding woman presented with brownish-white skin lesions with a line configuration and hardened skin on the right shoulder, upper arm, forearm, hand, and fingers. The histopathological findings demonstrated epidermal thinning with flattened rete ridges, thickened fibrocollagenous connective tissue stroma extending into the subcutaneous fat, hyaline degeneration, a mild lymphocytic inflammatory, and absence of pilosebaceous unit. The laboratory analysis revealed a positive ANA test with a titer of 1:320 and the presence of anti-RNP and anti-Sm autoantibodies. The patient received hydroxychloroquine (HCQ) 200 mg twice daily and topical pimecrolimus 1% cream twice daily. After three months of observation, there was an improvement in the skin lesions. In addition, the modified localized skin index (mLoSSI) score and the localized scleroderma damage index (LoSDI) score decreased from 6 to 1 and 5 to 4, respectively. No adverse effects related to retinal toxicity were reported during the course of therapy. Conclusion: This case suggests that the combination of oral HCQ and topical pimecrolimus may represent a safe and effective therapeutic option for LM in breastfeeding women, although further evidence is needed to confirm long-term outcomes.
- 1 December 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 5787-5795
Open AccessCombination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome
Background: Linear morphea (LM) is a chronic autoimmune disease characterized by linear or band-like localized sclerosis that may involve the dermis, subcutaneous tissue, muscle, and underlying bone. While LM typically presents in childhood, adult-onset disease is considerably less common, and LM presenting during breastfeeding has not, to our knowledge, been previously documented. As a result, therapeutic guidance for managing LM in breastfeeding women remains extremely limited, highlighting the need for additional clinical evidence in this population. Case Presentation: A 44-year-old breastfeeding woman presented with brownish-white skin lesions with a line configuration and hardened skin on the right shoulder, upper arm, forearm, hand, and fingers. The histopathological findings demonstrated epidermal thinning with flattened rete ridges, thickened fibrocollagenous connective tissue stroma extending into the subcutaneous fat, hyaline degeneration, a mild lymphocytic inflammatory, and absence of pilosebaceous unit. The laboratory analysis revealed a positive ANA test with a titer of 1:320 and the presence of anti-RNP and anti-Sm autoantibodies. The patient received hydroxychloroquine (HCQ) 200 mg twice daily and topical pimecrolimus 1% cream twice daily. After three months of observation, there was an improvement in the skin lesions. In addition, the modified localized skin index (mLoSSI) score and the localized scleroderma damage index (LoSDI) score decreased from 6 to 1 and 5 to 4, respectively. No adverse effects related to retinal toxicity were reported during the course of therapy. Conclusion: This case suggests that the combination of oral HCQ and topical pimecrolimus may represent a safe and effective therapeutic option for LM in breastfeeding women, although further evidence is needed to confirm long-term outcomes.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 18, 3645-3652
Combination of Hyaluronic Acid and Polynucleotides Injection for the Treatment of Cheilitis Simplex
Cheilitis simplex is a prevalent form of cheilitis that is characterized by the presence of cracked lips, fissures, or desquamation, due to various etiologies. Utilization of “boosters” as a treatment for chapped lips has not been extensively researched. This case report aimed to describe the efficacy of lip booster injection comprising active ingredients of 1% hyaluronic acid (HA) and 1% polynucleotides (PN), with 0.3% lidocaine as anesthetic agent. A 30-year-old female patient presented with a chief complaint of dry and chapped lips that occasionally bleed. This condition had recently deteriorated, and the application of topical treatment had not yielded substantial improvement, which led to a state of distress for the patient. She was diagnosed with cheilitis simplex and was subsequently treated with a single subdermal injection of a combination of 1% HA, 1% PN, and 0.3% lidocaine. Lip hydration was increased gradually, as measured by tewameter, with peak rate of hydration (26.218 g/m2/h) occurred two weeks after injection, and subsequently decreased gradually until six weeks after injection (29.926 g/m2/h); however, the rate of hydration remained higher than the baseline value (34.386 g/m2/h). Additionally, the lips exhibited an increase in brightness and a shift in pigmentation toward a rosier hue, as substantiated by spectrophotometric analysis. The mechanism of HA and PN include providing hydration and stimulating dermal fibroblast activity. However, PN may also exert an additional effect of improving lip pigmentation by reducing melanin and increasing hemoglobin levels. In conclusion, the lip booster injection, comprising 1% PN, 1% non-cross-linked HA, and 0.3% lidocaine, is an efficacious and practical treatment option for cheilitis simplex. This treatment option offers the additional benefits of being pain-free and enhancing lip pigmentation. Further studies are required to confirm these findings.
- 1 December 2025
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 18, 3645-3652
Open AccessCombination of Hyaluronic Acid and Polynucleotides Injection for the Treatment of Cheilitis Simplex
Cheilitis simplex is a prevalent form of cheilitis that is characterized by the presence of cracked lips, fissures, or desquamation, due to various etiologies. Utilization of “boosters” as a treatment for chapped lips has not been extensively researched. This case report aimed to describe the efficacy of lip booster injection comprising active ingredients of 1% hyaluronic acid (HA) and 1% polynucleotides (PN), with 0.3% lidocaine as anesthetic agent. A 30-year-old female patient presented with a chief complaint of dry and chapped lips that occasionally bleed. This condition had recently deteriorated, and the application of topical treatment had not yielded substantial improvement, which led to a state of distress for the patient. She was diagnosed with cheilitis simplex and was subsequently treated with a single subdermal injection of a combination of 1% HA, 1% PN, and 0.3% lidocaine. Lip hydration was increased gradually, as measured by tewameter, with peak rate of hydration (26.218 g/m2/h) occurred two weeks after injection, and subsequently decreased gradually until six weeks after injection (29.926 g/m2/h); however, the rate of hydration remained higher than the baseline value (34.386 g/m2/h). Additionally, the lips exhibited an increase in brightness and a shift in pigmentation toward a rosier hue, as substantiated by spectrophotometric analysis. The mechanism of HA and PN include providing hydration and stimulating dermal fibroblast activity. However, PN may also exert an additional effect of improving lip pigmentation by reducing melanin and increasing hemoglobin levels. In conclusion, the lip booster injection, comprising 1% PN, 1% non-cross-linked HA, and 0.3% lidocaine, is an efficacious and practical treatment option for cheilitis simplex. This treatment option offers the additional benefits of being pain-free and enhancing lip pigmentation. Further studies are required to confirm these findings.